Tcelltech Gmbh
Tcelltech GmbH, a spin-out of the German Cancer Research Center (DKFZ), envisages developping a universal personalised adoptive cell therapy against all cancers (UNIPACT). UNIPACT is based on two platform technologies:(I) High performance gene expressing DNA vector (nanoSMAR)(II) AI bioinformatics platform for reactive T cell receptor identification (selecTCR). Managing Directors: Prof. Dr. Michael Platten, Dr. Edward Green, Dr. Richard Harbottle, Dr. Mathias Turwitt HRB 745600 AG Mannheim
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Tcelltech Gmbh
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Tcelltech Gmbh
2 distinct titles indexed · top 2 shown.
- 1co-founder of tcelltech gmbh
- 1co-founder, finance
Sign up to unlock all 2 contacts at Tcelltech Gmbh
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Tcelltech Gmbh
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.